Mechanistically, we for the first time demonstrated that SND1 and β-catenin were direct functional targets of miR-320a in gliomas, which facilitated our understanding of the mechanisms underlying glioma malignant progression. This evidence concerns the gene SND1 and central nervous system cancer.